startup.bid
SW
EnglishEspañolPortuguêsFrançaisDeutschItalianoNederlandsSvenskaDanskNorskPolskiSlovenščinaTürkçeРусскийBahasa IndonesiaBahasa MelayuFilipinoTiếng ViệtKiswahiliहिन्दीاردوالعربيةעברית日本語한국어中文繁體中文

Rejuvenation Technologies Inc.

mRNA therapeutics to extend healthspan entering clinical trials

Kuhusu

Maelezo ya kampuni kwa Kiingereza

Stanford-patented essential drug platform unlocks the healthspan, which is limited by short telomeres. Extends mouse lifespan by equivalent of 10 years in humans. Reverses 5-10 years of telomere shortening with one dose in one day. Preclinical efficacy in 4 organ systems including immune system. Entering clinical stage. CEO is Subject #1 in longevity trial. 50+ granted patents, 7 patent families. FDA INTERACT cleared. Raising $10M seed extension ($2M+ wired) to fund 3 investigator-initiated trials. Readouts in Q3 2027. $6.8B in comparable mRNA-LNP M&A in last 12 months.

Mada

Anti-AgingGene TherapyNanomedicineHealthcareTherapeutics
Eneo
San Francisco, CA, Marekani
Ukubwa wa timu
Wafanyakazi: 2
Kundi la YC
Summer 2018
Hali
Inafanya kazi
Hatua
Hatua za awali

Startup zinazofanana na washindani

Maswali na majibu

Makao makuu ya Rejuvenation Technologies Inc. yako wapi?

San Francisco, CA, Marekani

Watu wangapi wanafanya kazi katika Rejuvenation Technologies Inc.?

Wafanyakazi: 2, kulingana na wasifu wa kampuni.

Je, Rejuvenation Technologies Inc. imepata ufadhili?

Hakuna awamu za ufadhili za Rejuvenation Technologies Inc. katika takwimu zetu.

Ni zipi mbadala za Rejuvenation Technologies Inc.?

Startup zinazofanana: Sixfold Bioscience, Nuntius Therapeutics na 64x Bio.